Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnesium transporter protein SLC41A1 is a plasma membrane transporter that mediates transmembrane magnesium ion (Mg2+) flux, playing a central role in cellular magnesium homeostasis. SLC41A1 belongs to the solute carrier 41 family and shares homology with the bacterial MgtE transporter family. Its expression is regulated by extracellular magnesium concentration and involves endosomal recycling via its N-terminal cytoplasmic domain. Mutations in SLC41A1 have been found in susceptibility loci for Parkinson's disease in humans, although the precise mechanisms by which it contributes to disease remain under investigation. SLC41A1's transport function is selective for magnesium but may also facilitate flux of other divalent cations like Fe2+, Zn2+, Cu2+, and Cd2+ under certain conditions, raising concerns about heavy metal toxicity in states of magnesium depletion[1][2][3][4]. SLC41A1 also regulates circadian cellular Mg2+ fluctuations, influencing metabolism and clock-controlled gene expression[5].
Facilitation of Mg2+ transport across cell membranes; proposed Na+/Mg2+ exchanger in some contexts
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnesium transporter protein SLC41A1 (SLC41A1).